The China Mail - Cate Blanchett nabs second Venice best actress award

USD -
AED 3.6725
AFN 66.000631
ALL 78.935002
AMD 365.260055
ANG 1.789783
AOA 916.999796
ARS 1497.230792
AUD 1.404297
AWG 1.8
AZN 1.69594
BAM 1.673104
BBD 2.01539
BDT 122.281202
BGN 1.696366
BHD 0.37701
BIF 2982.5
BMD 1
BND 1.271932
BOB 11.542986
BRL 5.1951
BSD 1.000659
BTN 95.718306
BWP 13.434508
BYN 3.043612
BYR 19600
BZD 2.012524
CAD 1.378155
CDF 2275.000389
CHF 0.80011
CLF 0.023446
CLP 922.769881
CNY 6.72325
CNH 6.72402
COP 3076.35
CRC 453.402228
CUC 1
CUP 26.5
CVE 94.824987
CZK 20.652098
DJF 177.719882
DKK 6.397295
DOP 59.010018
DZD 133.042028
EGP 50.8813
ERN 15
ETB 163.449465
EUR 0.85575
FJD 2.19785
FKP 0.735015
GBP 0.733135
GEL 2.604997
GGP 0.735015
GHS 11.125008
GIP 0.735015
GMD 73.000151
GNF 8777.499549
GTQ 7.635945
GYD 209.26741
HKD 7.843495
HNL 26.831146
HRK 6.447197
HTG 130.914597
HUF 312.1415
IDR 17771.6
ILS 2.99765
IMP 0.735015
INR 95.77255
IQD 1310.845723
IRR 1374575.000017
ISK 121.520065
JEP 0.735015
JMD 158.313693
JOD 0.709017
JPY 159.008502
KES 129.420125
KGS 87.4491
KHR 4045.000094
KMF 422.000199
KPW 900.000294
KRW 1390.3502
KWD 0.30823
KYD 0.833925
KZT 456.002874
LAK 22475.000128
LBP 89550.000074
LKR 330.163782
LRD 181.62496
LSL 16.139929
LTL 2.95274
LVL 0.60489
LYD 6.354988
MAD 9.25375
MDL 17.181525
MGA 4276.542323
MKD 52.679573
MMK 2099.608389
MNT 3598.398104
MOP 8.084231
MRU 40.129915
MUR 46.649692
MVR 15.459825
MWK 1737.000161
MXN 16.949207
MYR 4.046005
MZN 63.904999
NAD 16.139821
NGN 1348.240212
NIO 36.828238
NOK 9.347235
NPR 153.148806
NZD 1.67942
OMR 0.384498
PAB 1.000654
PEN 3.354006
PGK 4.498929
PHP 61.730497
PKR 277.574971
PLN 3.694825
PYG 6025.116772
QAR 3.647726
RON 4.4936
RSD 100.426983
RUB 82.799646
RWF 1470.917848
SAR 3.756633
SBD 8.032258
SCR 13.744502
SDG 601.4985
SEK 9.478705
SGD 1.27155
SHP 0.740866
SLE 24.536401
SLL 20969.499227
SOS 571.883194
SRD 37.689803
STD 20697.981008
STN 20.959339
SVC 8.755908
SYP 13001.999906
SZL 16.142113
THB 32.835031
TJS 9.246023
TMT 3.5
TND 2.9105
TOP 2.40776
TRY 48.059199
TTD 6.781357
TWD 31.855803
TZS 2645.502978
UAH 44.634778
UGX 3722.127883
UYU 40.105225
UZS 11847.637787
VES 776.44435
VND 26102
VUV 118.216132
WST 2.729275
XAF 561.160206
XAG 0.014686
XAU 0.000221
XCD 2.70255
XCG 1.803429
XDR 0.707052
XOF 561.165007
XPF 102.02362
YER 237.075034
ZAR 16.11691
ZMK 9001.208288
ZMW 18.886955
ZWL 321.999592
  • RBGPF

    0.3500

    69.35

    +0.5%

  • CMSC

    -0.0799

    21.28

    -0.38%

  • VOD

    -0.1600

    16.01

    -1%

  • RYCEF

    -0.1800

    20.42

    -0.88%

  • GSK

    -0.9200

    51.96

    -1.77%

  • BTI

    0.7200

    56.7

    +1.27%

  • RELX

    0.2800

    35.38

    +0.79%

  • NGG

    -0.0400

    80.62

    -0.05%

  • RIO

    1.7300

    102.17

    +1.69%

  • BCE

    0.0800

    23.78

    +0.34%

  • BP

    1.4100

    45.14

    +3.12%

  • CMSD

    -0.0300

    21.12

    -0.14%

  • BCC

    -1.3600

    81.77

    -1.66%

  • AZN

    -0.4600

    164.49

    -0.28%

  • JRI

    0.0300

    12.41

    +0.24%

Cate Blanchett nabs second Venice best actress award
Cate Blanchett nabs second Venice best actress award / Photo: © AFP

Cate Blanchett nabs second Venice best actress award

Considered one of the greatest actresses of her generation, Cate Blanchett won the best actress award in Venice for a second time on Saturday.

Text size:

Blanchett won in 2007 for her gender-bending performance as Bob Dylan in "I'm Not There", and also headed the Venice Film Festival jury in 2020.

This time, the 53-year-old won for her complex and challenging role in "Tar" as a renowned classical music conductor accused of inappropriate liaisons with female colleagues.

The film tackles several hot-button issues including the MeToo movement, political correctness, and women in positions of power.

But Blanchett told journalists in Venice that she wasn't interested in "agitprop", or political propaganda through art.

"I don't see artistic practice as an education tool," she said.

After a film comes out, she said, "it can be politicised, discussed, people can be disgusted with it, offended by it, inspired by it, but that's outside our control."

- 'Best and bravest' -

Born in Melbourne on May 14, 1969, Blanchett began her career onstage, before working her way into increasingly high-profile film roles.

She made her breakthrough performance in 1998, playing the 16th century British monarch in "Elizabeth", which won her a slew of awards and her first Oscar nomination.

Only a year earlier, she had been on the public side of the barrier on her first trip to Cannes, having to beg for a ticket to get into one of the premieres.

By 1999, she was back in Cannes, but this time as a star, presenting "An Ideal Husband".

Since then, her star has never stopped rising.

She has been nominated seven times at the Academy Awards, winning the supporting actress statuette for a pitch-perfect impression of Katherine Hepburn in "The Aviator" in 2004.

She won the top acting prize in 2013 for her performance as the wife of a disgraced high-society mogul in Woody Allen's "Blue Jasmine".

Blanchett has also dabbled in blockbusters, appearing in "Indiana Jones and the Kingdom of the Crystal Skull", "Robin Hood", "Cinderella" and "Thor: Ragnarok", as well as her iconic appearances in all of Peter Jackson's "Lord of the Rings" films.

But it is parts in more indie fare that have built her reputation, from the wealthy socialite in "The Talented Mr Ripley" to the crusading Irish journalist in "Veronica Guerin" or another heavily-accented (and pregnant) reporter in Wes Anderson's "The Life Aquatic with Steve Zissou".

She starred in the much-loved same-sex romance "Carol" in 2015, for which she earned her seventh Academy Award nomination.

She has repeatedly returned to the stage, to similar levels of acclaim. The New York Times described her as "one of the best and bravest actresses on the planet" after watching her in 2011's production of "Uncle Vanya".

Along with her writer husband Andrew Upton, Blanchett became artistic director of the Sydney Theatre Company from 2008 to 2013.

S.Davis--ThChM